It is time to review and update the MCC Risk Assessment and Mitigation Management Tool v1.0 (RA&MMT) that was launched in 2015 and uses definitions from the publicly available RACT tool (TransCelerate Biopharma) along with a number of additional features.
The MCC is seeking feedback from all who have seen or used RA&MMT to further develop, improve and update the tool to align with ICH E6 (R2). The survey will take less than 10 minutes to complete and all responses will remain confidential
MCC member organizations are invited to join the MCC Study Quality Trailblazer Work Group at a meeting on March 14, 2018 to review the results and help develop the updated tool. Log in to the member portal on the MCC website and click on the Study Quality Trailblazer Work Group link to register.
Take the survey Here